Work in a rat model of spontaneous hypertension (exhibits hypertension, insulin resistance and dyslipidemia, features of metabolic syndrome) showed that knocking out the CFB gene improved glucose tolerance and insulin sensitivity, with redistribution of visceral to subcutaneous fat. This evidence concerns the gene INS and metabolic syndrome.